LISOFER 30
Natural health product licensed in Canada
- Licence holder
- Canadex Laboratories Inc.
- NPN or DIN-HM
- 80072384
- Status
- Active licence
- Licence date
- 1 September 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Fer: up to 30 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Fer Source : Pyrophosphate de fer (III) | 30 milligramme | 30,000 µg |
| Folate Source : Folate | 1,000 microgrammes | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 2.5 microgrammes | Not calculated |
Non-medicinal ingredients
FD&C Red no 3 Lake, Lécithine, Hydroxypropyl amidon, Rouge FD&C no 40, Hydroxypropyl methylcellulose, Stéarate de magnésium, Dioxyde de titane, Colloidal silicon dioxide, Povidone, Acide stéarique, Amidon de maïs modifié, Glycolate d'amidon sodique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce the risk of neural tube defects when taken daily prior to becoming pregnant and during early pregnancy. Helps to prevent iron deficiency anemia, helps to prevent vitamin B12 deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80072384
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.